Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiovascular and renal actions of dopamine: potential clinical applications.

× No keyword cloud information.

192 in total

1. In vivo venodilator action of fenoldopam, a dopamine D(1)-receptor agonist.

Authors: S S Ng; C C Pang
Journal: Br J Pharmacol Date: 2000-03 Impact factor: 8.739

Review 2. Can the use of low-dose dopamine for treatment of acute renal failure be justified?

Authors: C J Burton; C R Tomson
Journal: Postgrad Med J Date: 1999-05 Impact factor: 2.401

3. Acute circulatory effects of dopamine in patients with pulmonary hypertension.

Authors: E L Holloway; R A Polumbo; D C Harrison
Journal: Br Heart J Date: 1975-05

4. Inhibition by dopamine of 3H-noradrenaline release elicited by nerve stimulation in the isolated cat's nictitating membrane.

Authors: M A Enero; S Z Langer
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1975 Impact factor: 3.000

5. The effect of dopamine on glomerular filtration rate in normotensive, oliguric premature neonates.

Authors: Susan K Lynch; Kevin V Lemley; Mark J Polak
Journal: Pediatr Nephrol Date: 2003-05-16 Impact factor: 3.714

Review 6. Anaesthetic management of the brain dead for organ donation.

Authors: A W Gelb; K M Robertson
Journal: Can J Anaesth Date: 1990-10 Impact factor: 5.063

7. Effects of the dopaminergic agonist cianergoline on blood pressure, the renin-angiotensin-aldosterone axis and the sympathetic nervous system in patients with essential hypertension.

Authors: G Bise; C Foletti; C Beretta-Piccoli; P Weidmann; W H Ziegler; R Mordasini; C Bachmann
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

8. Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors: R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal: Br J Pharmacol Date: 1985-07 Impact factor: 8.739

9. Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.

Authors: J N Harvey; D P Worth; J Brown; M R Lee
Journal: Br J Clin Pharmacol Date: 1986-01 Impact factor: 4.335

10. Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.

Authors: A G Dupont; P Vanderniepen; A M Bossuyt; M H Jonckheer; R O Six
Journal: Br J Clin Pharmacol Date: 1985-08 Impact factor: 4.335